gemcitabine medac 1500 milligram pdr for soln for infusion
medac gesellschaft fur klinische spezialpraparate - gemcitabine - pdr for soln for infusion - 1500 milligram
gemcitabine medac 1 grams pdr for soln for infusion
medac gesellschaft fur klinische spezialpraparate - gemcitabine - pdr for soln for infusion - 1 grams
gemcitabine medac 200 milligram pdr for soln for infusion
medac gesellschaft fur klinische spezialpraparate - gemcitabine - pdr for soln for infusion - 200 milligram
metoject 50 mg/ml solution for injection, pre-filled syringe
medac gesellschaft für klinische spezialpräparate mbh - methotrexate - solution for injection in pre-filled syringe - 50 milligram(s)/millilitre - other immunosuppressants; methotrexate
oxaliplatin medac 5 mg/ml powder for solution for infusion
medac gesellschaft für klinische spezialpräparate mbh - oxaliplatin - powder for solution for infusion - 5 milligram(s)/millilitre - platinum compounds; oxaliplatin
oxamed 5 mg/ml pdr for soln for infusion
medac gesellschaft fur klinische spezialpraparate - oxaliplatin - pdr for soln for infusion - 5 mg/ml
sodiofolin 50 mg/ml solution for injection
medac gesellschaft fur klinische spezialpraparate - folinic acid - solution for injection - 50 mg/ml
treosulfan capsule 250 mg 250 mg milligram capsule
medac gesellschaft fur klinische spezialpraparate - treosulfan - capsule - 250 mg milligram
capecitabine medac
medac gesellschaft für klinische spezialpräparate mbh - capecitabine - colorectal neoplasms - antineoplastic agents - capecitabine medac is indicated for the adjuvant treatment of patients following surgery of stage-iii (dukes’ stage-c) colon cancer.capecitabine medac is indicated for the treatment of metastatic colorectal cancer.capecitabine medac is indicated for first-line treatment of advanced gastric cancer in combination with a platinum-based regimen.capecitabine medac in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. previous therapy should have included an anthracycline.capecitabine medac is also indicated as monotherapy for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline-containing chemotherapy regimen or for whom further anthracycline therapy is not indicated.
zoledronic acid medac
medac gesellschaft für klinische spezialpräparate mbh - zoledronic acid monohydrate - fractures, bone; cancer - drugs for treatment of bone diseases - prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone.treatment of adult patients with tumour-induced hypercalcaemia (tih).